Head-to-head comparisons of medication uses, side effects, warnings, and more.
Actemra (tocilizumab)
Kevzara (sarilumab)
Actemra (tocilizumab)
Kevzara (sarilumab)
Summary of Actemra vs. Kevzara
Summary for IL-6 receptor antagonist
Prescription only
Actemra (tocilizumab) is an interleukin-6 (IL-6) receptor antagonist. It treats several inflammatory conditions in children and adults, including rheumatoid arthritis. It works by blocking IL-6, a chemical released by the immune system that causes inflammation and fever. Actemra (tocilizumab) is given as an injection (either through the veins or under the skin), typically weekly or every few weeks, depending on the condition you're taking it treat. Side effects include a higher risk of infections and headache.
Summary for IL-6 inhibitor
Prescription only
Kevzara (sarilumab) treats certain adults with rheumatoid arthritis (RA) or polymyalgia rheumatica (PMR). It can also help treat children with polyarticular juvenile idiopathic arthritis (pJIA). This medication is a biologic called an interleukin antagonist. It works to lessen inflammation and stiffness in the joints. Kevzara (sarilumab) is an injection that you give under the skin every 2 weeks. Side effects include pain and itchiness at the injection site.